page 881), some cancerous cells can probably get by with very little matrix by making their own costimulator.
That costimulator is melanoma chondroitin sulfate proteoglycan (MCSP). MCSP is known to be an early cell surface marker during melanoma progression, and to stimulate tumorigenesis. When Yang et al. transfected MCSP into a melanoma cell lacking MCSP, the cells exhibited an increased propensity to undergo spreading, which was mediated in large part by focal adhesion kinase (FAK). Integrin-mediated activation of both FAK and ERK 1/2 were increased by MCSP expression, and activation of ERK 1/2 remained even when FAK activity was inhibited.
MCSP is up-regulated early in melanoma (even in precancerous lesions), and its expression is maintained in the vast majority of melanomas throughout progression. The authors speculate that MCSP may function to lessen the requirement by tumor cells for ligands in the tumor microenvironment, giving cells that express this cell surface proteoglycan a selective advantage. ▪